Fortis Inc. enters its Q1 reporting season — results now confirmed for May 6 — carrying the most notable short-side repositioning it has seen in months, even as the stock itself holds up and analysts have just turned more constructive.
The most striking development this week is the jump in short interest. Estimated short interest climbed 45% over seven days, moving from roughly 5.2 million shares to 7.5 million shares, or about 1.5% of the free float. That is still a modest absolute level for a utility, but the pace of the build is unusual. The step-change happened over the weekend of April 19-20 and has held flat since, suggesting a deliberate repositioning rather than a short-lived tactical trade. At 1.5% of float, shorts are not crowded — but they are clearly more interested than they were a month ago, when the figure was roughly 32% lower.
The lending market tells a calmer story. Borrow costs have actually eased from their recent highs. Cost to borrow dropped roughly 43% over the week to 0.66%, down from a mid-month peak above 1.4%. Availability in the lending pool remains high — the share of available inventory relative to outstanding shorts points to no squeeze dynamic whatsoever, consistent with an availability reading well into loose territory. The ORTEX short score is a benign 33.3, sitting at the 53rd percentile of the universe and barely moving week over week. This is a stock where shorts have added notional exposure, but where the borrow market is giving them no friction at all.
Barclays upgraded FTS to Strong Buy on April 29, the day before this note. That is the most meaningful analyst development of the week and directly contradicts the short build. The consensus remains at buy, with the mean analyst price target at CAD 78.10 against a current price of CAD 76.99 — implying modest upside but reasonable alignment. The dividend score ranks in the 99th percentile of the ORTEX universe, which is the stock's strongest single signal. Fortis has a 52-year track record of consecutive dividend increases, and with annual revenue around CAD 9.6 billion, EBITDA near CAD 4.5 billion, and an EV/EBITDA of around 12.4x, the valuation sits in a range that leaves little for either side to celebrate. The analyst recommendation divergence factor ranks at the 91st percentile — meaning the Street is unusually aligned in a positive direction relative to the stock's historical consensus profile.
Institutional ownership is deep and stable. BlackRock holds 6.7% of shares and added a substantial position in the latest reporting period. BMO Asset Management (4.8%) and Vanguard (4.7%) also made incremental additions. The one notable trim came from RBC Dominion Securities, which reduced its holding by nearly 1.8 million shares as of end-December. On the insider front, four independent directors picked up small parcels on April 1 — routine director reinvestment, low significance individually but collectively signalling comfort at current price levels. The more meaningful insider activity was in February, when the president and CFO of a major subsidiary sold shares worth over USD 3 million in aggregate; those transactions were tied to award exercises and are now more than two months old.
The last earnings print on February 12 produced a clean 4.6% single-day gain and a nearly identical 4.6% five-day follow-through — a constructive historical pattern heading into May 6. Peers had a roughly parallel week: EMA and H on the TSX gained 2.3% and 1.6% respectively on the week, while US utilities DUK and SO added just over 1% each — all moving in the same quiet, defensive-rotation direction as FTS's own 1.6% weekly gain.
With Q1 results now rescheduled to May 6 and Barclays' upgrade still fresh, the setup heading into the print is: a rising short position against a newly bullish bellwether rating, in a lending market too loose to force anyone's hand.
See the live data behind this article on ORTEX.
Open FTS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
